1
← Back to quizzesFree quiz
Bronchiectasis (Dilatation des bronches)
Bronchiectasis, also known as dilatation des bronches, is a chronic condition characterized by permanent enlargement of the bronchi. This course explores the anatomical definition,…
0 / 21
Score: 0%
2
A 25‑year‑old patient presents with chronic productive cough, recurrent infections and a CT scan showing ‘tram‑track’ sign. Which etiological category is most likely responsible?
3
In the microscopic description of bronchiectasis, which cell type shows metaplasia and contributes to mucus hypersecretion?
4
Which radiological feature distinguishes bronchiectatic cystic lesions from simple bronchial dilatation on CT?
5
A patient with bronchiectasis secondary to cystic fibrosis is being evaluated for long‑term macrolide therapy. What is the primary therapeutic goal of this treatment?
6
Which of the following systemic diseases is NOT listed among the acquired causes of bronchiectasis in the text?
7
During bronchoscopy for a patient with suspected bronchiectasis, which laboratory criterion indicates a high‑quality distal sputum sample for microbiological analysis?
8
Which clinical sign listed in the diagnostic section is specifically associated with chronic respiratory disease and may suggest bronchiectasis when present?
9
In the therapeutic algorithm, which intervention is indicated specifically for massive hemoptysis in bronchiectasis patients?
10
Which of the following statements about the role of physiotherapy in bronchiectasis is most accurate?
11
A patient with bronchiectasis undergoes a CT scan that shows ‘tram‑track’ and ‘signet‑ring’ signs. Which pathological process underlies these imaging findings?
12
Which genetic disorder listed is directly linked to a mutation in the CFTR gene and predisposes to bronchiectasis?
13
When evaluating a patient with bronchiectasis, which laboratory test is specifically recommended to assess for cystic fibrosis in adults?
14
Which of the following statements correctly reflects the prognostic distinction between localized and extensive forms of bronchiectasis?
15
In the context of bronchiectasis, which complication is most directly linked to chronic infection and may lead to systemic sepsis?
16
Which of the following best explains why a normal chest X‑ray does not exclude bronchiectasis?
17
A patient with bronchiectasis is found to have a persistent Pseudomonas aeruginosa colonization. Which therapeutic option is specifically indicated for this scenario?
18
Which systemic autoimmune disease listed is associated with bronchiectasis and may require specific serological testing?
19
When assessing the functional impact of bronchiectasis, which pulmonary function test parameter is most indicative of obstructive airway disease?
20
Which of the following preventive measures is emphasized as a cornerstone in the long‑term management of bronchiectasis?
21
In the diagnostic work‑up, which investigation is primarily used to identify a local obstructive cause such as a foreign body in bronchiectasis patients?
Understanding Bronchiectasis: Definition, Causes, and Diagnosis
Bronchiectasis, also known as dilatation des bronches, is a chronic condition characterized by permanent enlargement of the bronchi. This course explores the anatomical definition, etiological categories, microscopic changes, radiological features, clinical signs, and therapeutic strategies associated with bronchiectasis. The content is organized to support both learning and search engine optimization (SEO) by using clear headings, keyword‑rich paragraphs, and semantic HTML.
1. Anatomical Definition
The core definition of bronchiectasis is essential for medical students and clinicians:
- Irreversible permanent enlargement of the 4th and 8th order bronchi with loss of the elastic‑muscular framework.
- This distinguishes it from transient bronchi dilation, hyperinflation of alveolar spaces, or bronchial narrowing due to fibrosis.
Understanding this definition helps differentiate bronchiectasis from other airway diseases such as asthma or chronic obstructive pulmonary disease (COPD).
2. Etiological Categories
Bronchiectasis can arise from a wide range of causes. The most common categories include:
- Infectious (acquired) causes – especially atypical mycobacterial infections, which often present with a “tram‑track” sign on CT scans.
- Congenital disorders such as primary ciliary dyskinesia (Kartagener syndrome) and cystic fibrosis.
- Systemic inflammatory diseases (e.g., rheumatoid arthritis, Sjögren’s syndrome, ulcerative colitis).
- Rare genetic or structural abnormalities of cartilage.
Among the systemic diseases listed, systemic lupus erythematosus (SLE) is NOT typically cited as an acquired cause of bronchiectasis, highlighting the importance of precise disease association.
3. Microscopic Changes
On histopathology, bronchiectasis shows characteristic cellular alterations:
- Metaplasia of the Malpighian epithelium (pseudostratified columnar ciliated cells) into mucus‑secreting goblet cells, contributing to mucus hypersecretion.
- Chronic neutrophilic inflammation with abundant polymorphonuclear leukocytes.
- Destruction of the elastic‑muscular layer of the bronchial wall.
These microscopic findings explain the clinical presentation of chronic productive cough and recurrent infections.
4. Radiological Features
High‑resolution computed tomography (HRCT) is the gold standard for diagnosing bronchiectasis. Key imaging signs include:
- Tram‑track sign – parallel bronchial walls indicating dilated airways.
- Signet‑ring sign – a dilated bronchus adjacent to a smaller artery.
- Distinguishing bronchiectatic cystic lesions from simple bronchial dilatation: cystic, air‑filled spaces that do not reduce in diameter near the hilum are characteristic of bronchiectasis.
These radiological markers help differentiate bronchiectasis from other cystic lung diseases such as pulmonary cysts or honey‑comb fibrosis.
5. Clinical Presentation and Physical Signs
Patients typically present with:
- Chronic productive cough lasting months to years.
- Recurrent lower‑respiratory infections.
- Digital clubbing (hippocratisme digital), a hallmark sign of chronic hypoxemia and long‑standing respiratory disease.
Other systemic signs such as jaundice, peripheral edema, or cyanosis are not specific for bronchiectasis and should prompt evaluation for alternative diagnoses.
6. Bronchoscopy and Sputum Sampling
When bronchoscopy is performed, obtaining a high‑quality distal sputum sample is crucial for microbiological analysis. The optimal laboratory criterion is:
- Polymorphonuclear neutrophils >25 per high‑power field (HPF) and epithelial cells
This cellular profile indicates a true lower‑airway specimen rather than contamination from the upper airway.
7. Therapeutic Goals
Management of bronchiectasis focuses on reducing disease progression and preventing exacerbations. In patients with cystic fibrosis‑related bronchiectasis, long‑term macrolide therapy aims to:
- Reduce the frequency of infectious exacerbations, thereby improving quality of life and slowing lung function decline.
- Modulate inflammation and disrupt bacterial biofilms.
It does not reverse the structural airway changes or correct the underlying CFTR mutation.
8. Summary of Key Points
To consolidate learning, remember the following essential concepts:
- Bronchiectasis = permanent, irreversible dilation of medium‑size bronchi (4th‑8th order) with loss of elastic‑muscular support.
- Most common acquired cause: atypical mycobacterial infection; congenital cause: cystic fibrosis.
- Metaplastic goblet cell hyperplasia drives mucus overproduction.
- CT signs (tram‑track, signet‑ring) differentiate bronchiectasis from simple bronchial dilation.
- Digital clubbing is a distinctive clinical clue.
- High‑quality sputum: >25 neutrophils/HPF,
- Macrolide therapy primarily reduces exacerbation frequency.
By mastering these concepts, healthcare professionals can accurately diagnose bronchiectasis, identify its underlying causes, and implement effective treatment strategies.
